"Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
| Descriptor ID |
D009374
|
| MeSH Number(s) |
C04.619 E05.598.500.496
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms, Experimental".
- Neoplasms, Experimental
- Carcinoma 256, Walker
- Carcinoma, Brown-Pearce
- Carcinoma, Ehrlich Tumor
- Carcinoma, Krebs 2
- Carcinoma, Lewis Lung
- Leukemia, Experimental
- Liver Neoplasms, Experimental
- Mammary Neoplasms, Experimental
- Melanoma, Experimental
- Sarcoma, Experimental
This graph shows the total number of publications written about "Neoplasms, Experimental" by people in this website by year, and whether "Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 2 | 3 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 1 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 1 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 4 | 2 | 6 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 1 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms, Experimental" by people in Profiles.
-
Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors. JCI Insight. 2021 09 08; 6(17).
-
Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer. J Immunother Cancer. 2020 05; 8(1).
-
Different oral cancer scenarios to personalize targeted therapy: Boron Neutron Capture Therapy translational studies. Ther Deliv. 2019 06 01; 10(6):353-362.
-
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
-
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
-
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018 07 02; 128(7):2787-2801.
-
A Unified Mathematical Model for Nano-Liposomal Drug Delivery to Solid Tumors. IEEE Trans Nanobioscience. 2018 03; 17(1):3-11.
-
NF-?B regulates GDF-15 to suppress macrophage surveillance during early tumor development. J Clin Invest. 2017 Oct 02; 127(10):3796-3809.
-
Estrogen and thyroid cancer is a stem affair: A preliminary study. Biomed Pharmacother. 2017 Jan; 85:399-411.
-
Pathology in Practice. J Am Vet Med Assoc. 2016 Nov 15; 249(10):1149-1151.